Halozyme Therapeutics
HALOHalozyme Therapeutics is a U.S. biotechnology company that develops novel oncology therapies designed to target the tumor microenvironment and licenses a novel drug delivery technology through corporate partnerships. The company was founded in 1998 and went public in 2004. Halozyme is headquartered …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2022-2024
All insider trades at Halozyme Therapeutics
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 4/17/2024 | Sell | Labarre, Michael J. | SVP, CHIEF TECHNICAL OFFICER | $38.5 | $384,890 |
| 4/16/2024 | Sell | Labarre, Michael J. | SVP, CHIEF TECHNICAL OFFICER | $38.4 | $383,500 |
| 3/13/2024 | Sell | Labarre, Michael J. | SVP, CHIEF TECHNICAL OFFICER | $42.3 | $422,730 |
| 3/12/2024 | Sell | Labarre, Michael J. | SVP, CHIEF TECHNICAL OFFICER | $41.6 | $416,370 |
| 2/28/2024 | Sell | Labarre, Michael J. | SVP, CHIEF TECHNICAL OFFICER | $39.6 | $395,463 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)